Schizophrenia

« Previous Entries

A Compound Derived From Cannabis Might Help Treat Schizophrenia

Thursday, June 1st, 2017

In a new study, the researchers tested a compound derived from cannabis on rats and found that it might improve cognitive impairment specific to schizophrenia, without causing side effects associated with current medication. This research might facilitate start of a new treatment for schizophrenia, which affects about 3.5 million people over 18 years in the […]

B Vitamins Might Reduce Symptoms of Schizophrenia

Saturday, February 18th, 2017

The current treatments of schizophrenia aim to remove the symptoms of this mental illness, chiefly because there’s no cure for it as of yet. A new study reveals B vitamins help reduces schizophrenia symptoms. It is estimated that about 1 percent of world’s population has schizophrenia. The condition affects men more than women. Common symptoms […]

Nicotine Might Help in Treatment of Schizophrenia

Tuesday, January 24th, 2017

The bad effects of smoking are many and well recorded. It increases risk of many diseases and shortens lifespan. However, according to a new research, nicotine might offer some benefit to people with schizophrenia. Characterised by hallucinations, delusions, and other cognitive impairments, Schizophrenia is a severe mental condition. It is estimated over 21 million individuals […]

Drug Abuse Increases Schizophrenia Risk

Saturday, October 22nd, 2016

Does substance abuse causes schizophrenia? This is a question many studies have investigated in the past without much success. No study was able to prove a link between the two conclusively. However, a new study, in which data of over three million individuals was studied, has stated conclusively that drug abuse increases schizophrenia risk. Previous […]

Smoking during Pregnancy Linked with Schizophrenia in Offspring

Thursday, May 26th, 2016

Expectant mothers who smoke increase their offspring’s risk to several health problems. A new study shows that smoking while pregnant might affect infant’s mental health also. An offspring’s risk to schizophrenia increases if the mother smokes during pregnancy. Smoking is bad for health all the time, but it becomes manifold more dangerous, especially for the […]

Scientists Find The Biological Cause of Schizophrenia

Friday, February 5th, 2016

No less than 21 million individuals worldwide suffer from schizophrenia, a mental disorder marked by impaired thought process, delusions, and hallucinations. Until now the exact cause of schizophrenia was not known. For the very first time, scientists have made a breakthrough discovery that shows the biological origin of this mental disorder. Almost two years back, […]

FDA approves aripiprazole lauroxil for schizophrenia

Wednesday, October 14th, 2015

The US Food and Drug Administration (FDA) has approved a new drug called aripiprazole lauroxil (brand name Aristada) for the treatment of adults with schizophrenia. The drug is an extended-release injection recommended to be administered every four-six weeks. Mitchell Mathis, director of the Division of Psychiatry Products in the Center for Drug Evaluation and Research, […]

Schizophrenia patients have below par physical health management

Thursday, October 30th, 2014

A new England and Wales national audit has found that schizophrenia patients have below-par physical ailment diagnosis and treatment. Mike Crawford of the Royal College of Psychiatrists, London, UK said that this may be due to a confusion regarding who is responsible for psychiatric patients’ physical health. The auditors said, “During the pilot phase of […]

Schizophrenia patients commonly cite hallucinations as suicide motive

Sunday, May 25th, 2014

A recent study suggests that delusions and hallucinations are common factors that trigger suicidal tendencies and attempts in schizophrenic patients. They were found to be the motive for 70.7 percent of the patients in the study. The study was done by Wataru Ukai and colleagues from Sapporo Medical University in Japan. A total of 65 […]

Similar failure rates for new and old schizophrenia medications

Thursday, May 22nd, 2014

Both oral and injectable medications are available for treating schizophrenia, with injections being known to last longer and helping patients to continue their treatment. A recent clinical trial has compared paliperidone palmitate, a new medication, and haloperidol decanoate, an older one. On comparing side effects, it was found that both medications were equally effective in […]

« Previous Entries